Showing results (631-640 of 1,188) with videos related to

Sort By:
Pageof 119
Canadian Journal of Kidney Health and Disease|March 28, 2020
Kidney Health for Everyone Everywhere: From Prevention to Detection and Equitable Access to CarePhilip Kam-Tao Li, Guillermo Garcia-Garcia, Siu-Fai Lui, et al.
Clinical Lymphoma & Myeloma|December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experienceFarhad Ravandi, Susan O'Brien, Dan Jones, et al.
Journal of Nephrology|April 2, 2020
Kidney health for everyone everywhere: from prevention to detection and equitable access to carePhilip Kam-Tao Li, Guillermo Garcia-Garcia, Siu-Fai Lui, et al.
Nature Reviews. Nephrology|November 14, 2020
Sustainable Development Goals relevant to kidney health: an update on progressValerie A Luyckx, Ziyad Al-Aly, Aminu K Bello, et al.
Clinical Nephrology|February 5, 2020
Kidney health for everyone everywhere - from prevention to detection and equitable access to carePhilip Kam-Tao Li, Guillermo Garcia-Garcia, Siu-Fai Lui, et al.
Cancer Medicine|March 18, 2024
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasmsKelly S Chien, Faustine Ong, Kunhwa Kim, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|May 13, 2020
Kidney health for everyone everywhere - from prevention to detection and equitable access to carePhilip Kam-Tao Li, Guillermo Garcia-Garcia, Siu-Fai Lui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndromeRazelle Kurzrock, Maher Albitar, Jorge E Cortes, et al.
International Journal of Hematology|February 22, 2018
Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR-ABL kinase domain mutationsKiran Naqvi, Jorge E Cortes, Raja Luthra, et al.
British Journal of Haematology|July 29, 2014
Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemiaChristopher B Benton, Deborah A Thomas, Hui Yang, et al.
Pageof 119